Glooko diabetes app
Users of the Eversense CGM will be able to transfer their data to Glooko's online diabetes management platform.
Digital diabetes care company Glooko announced today that its Mobile Insulin Dosing System (MIDS) — an app-driven tool that recommends insulin dose adjustments using data collected directly from a patient’s blood glucose meter — has been cleared by the FDA.